Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.34 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL31283578 | 0.97 | GSR (0.35) | GSRCA1RNPEPCPB2 | |
| SCHEMBL31283191 | 0.97 | GSR (0.35) | GSRCA1RNPEPCPB2 | |
| SCHEMBL31341035 | 0.97 | GSR (0.35) | GSRCA1RNPEPCPB2 | |
| SCHEMBL9716843 | 0.83 | GSR (0.46) | GSRRNPEPCPB2 | |
| SCHEMBL9716838 | 0.83 | GSR (0.46) | GSRRNPEPCPB2 | |
| Calcium SCHEMBL32679722 | 0.81 | GSR (0.44) | GSRRNPEPCPB2 | |
| SCHEMBL32679721 | 0.81 | GSR (0.44) | GSRRNPEPCPB2 | |
| Zinc Ion SCHEMBL31340961 | 0.79 | CPB2 (0.39) | GSRCA1RNPEPCPB2 | |
| SCHEMBL9716741 | 0.77 | GABRR1 (0.41) | GSRRNPEPCPB2 | |
| SCHEMBL9716745 | 0.77 | GABRR1 (0.41) | GSRRNPEPCPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746865-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND REJUVENATING SKIN AND EXTENDING LONGEVITY | Sytheon Ltd. (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260041620-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | SYTHEON LTD (US) | 2026-02-12 | — | — | US | disclosed |
| US-20250099355-A1 | AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | SYTHEON LTD (US) | 2025-03-27 | — | — | US | disclosed |
| WO-2025019570-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND REJUVENATING SKIN AND EXTENDING LONGEVITY | SYTHEON LTD. (US) | 2025-01-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099355-A1 | AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | AADAT, BCAT2, BCAT1 | GSR 1591/4885CA1 4690/4885RNPEP 175/4885 |
| US-20260041620-A1 | NOVEL AMINO ACID BASED SALTS, COMPOSITIONS AND METHODS FOR TREATING SKIN AND IMPROVING SKIN REJUVENATION AND LONGEVITY | TYR, ARG2, BCAT2 | GSR 340/4885CA1 3655/4885RNPEP 1714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.